Concomitant with patient-derived M-MDSC suppression by i-BET762, combined treatment with anti-PD-L1 synergistically enhanced tumor-infiltrating lymphocytes, resulting in tumor eradication and prolonging survival in the fibrotic-HCC mouse model (123). This evidence concerns the gene CD274 and hepatocellular carcinoma.